Nicola Wallis

The impact of dasatinib on pregnancy outcomes

Jörge E. Cortes, Elisabetta Abruzzese, Ekaterina Chelysheva et al. · American Journal of Hematology · 2015 · 125 citations · Full text

Medicine, Obstetrics, Oncology +14

Cardiovascular and pulmonary adverse events in patients treated with <i><scp>BCR</scp>‐<scp>ABL</scp></i> inhibitors: Data from the <scp>FDA</scp> Adverse Event Reporting System

Jörge E. Cortes, Michael J. Mauro, Juan Luis Steegmann et al. · American Journal of Hematology · 2015 · 61 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

In vitro and in vivo evaluation of dasatinib and imatinib on physiological parameters of pulmonary arterial hypertension

Bethany R. Baumgart, Mausumee Guha, James K. Hennan et al. · Cancer Chemotherapy and Pharmacology · 2017 · 15 citations

Medicine, Pharmacology, Pharmacotherapy +10

Peripheral Arterial Occlusive Disease (PAOD) In Patients (Pts) Receiving Dasatinib: Experience Across Multiple Clinical Trials

Philipp D. le Coutre, Timothy P. Hughes, François‐Xavier Mahon et al. · Blood · 2013 · 11 citations

Medicine, Hematology, Oncology +7